Newmont Corporation vs BIO-TECHNE Corp — how do they compare? Newmont Corporation trades at $92.41 (market cap $95.23B), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: Newmont Corporation is far larger — about 8.5× BIO-TECHNE Corp's market cap, and Newmont Corporation pays the higher dividend (1.17%). Which is the better fit depends on your goals.
| NEM | TECH | |
|---|---|---|
Market Cap | $95.23B | $11.16B |
Sector | Basic Materials | Health |
52-Week High | $131.95 | $72.12 |
52-Week Low | $59.86 | $43.31 |
Enterprise Value | $91.98B | $11.24B |
Dividend Yield | 1.17% | 0.45% |
Trailing returns across standard periods
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →